SG Americas Securities’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $201M | Buy |
1,944,296
+716,227
| +58% | +$63.9M | 0.11% | 129 |
|
|
2026
Q1 | $87.5M | Buy |
1,228,069
+147,827
| +14% | +$11.4M | 0.09% | 170 |
|
|
2025
Q4 | $85.7M | Buy |
1,080,242
+1,015,775
| +1,576% | +$80.1M | 0.11% | 145 |
|
|
2025
Q3 | $4.86M | Buy |
64,467
+37,148
| +136% | +$2.55M | 0.02% | 523 |
|
|
2025
Q2 | $1.88M | Sell |
27,319
-176,088
| -87% | -$11.5M | 0.01% | 802 |
|
|
2025
Q1 | $13.8M | Buy |
203,407
+174,606
| +606% | +$10.4M | 0.05% | 255 |
|
|
2024
Q4 | $1.29M | Buy |
28,801
+9,234
| +47% | +$518K | 0.01% | 752 |
|
|
2024
Q3 | $1.23M | Sell |
19,567
-315,372
| -94% | -$18.4M | ﹤0.01% | 922 |
|
|
2024
Q2 | $19.8M | Buy |
334,939
+131,836
| +65% | +$8.25M | 0.12% | 169 |
|
|
2024
Q1 | $16.2M | Buy |
203,103
+157,133
| +342% | +$12M | 0.08% | 262 |
|
|
2023
Q4 | $3.63M | Sell |
45,970
-65,597
| -59% | -$4.67M | 0.03% | 428 |
|
|
2023
Q3 | $7.79M | Sell |
111,567
-40,169
| -26% | -$2.85M | 0.09% | 203 |
|
|
2023
Q2 | $10.5M | Buy |
151,736
+102,165
| +206% | +$7.27M | 0.08% | 165 |
|
|
2023
Q1 | $3.68M | Buy |
49,571
+28,822
| +139% | +$2.42M | 0.04% | 377 |
|
|
2022
Q4 | $1.93M | Sell |
20,749
-43,905
| -68% | -$4.24M | 0.02% | 577 |
|
|
2022
Q3 | $6.17M | Buy |
64,654
+7,764
| +14% | +$769K | 0.08% | 229 |
|
|
2022
Q2 | $5.27M | Sell |
56,890
-23,385
| -29% | -$2.28M | 0.06% | 286 |
|
|
2022
Q1 | $8.13M | Sell |
80,275
-22,562
| -22% | -$2.37M | 0.06% | 263 |
|
|
2021
Q4 | $10.6M | Buy |
102,837
+27,548
| +37% | +$2.55M | 0.06% | 254 |
|
|
2021
Q3 | $6.39M | Sell |
75,289
-100,757
| -57% | -$8.44M | 0.03% | 434 |
|
|
2021
Q2 | $14.7M | Sell |
176,046
-153,644
| -47% | -$12.6M | 0.07% | 243 |
|
|
2021
Q1 | $24.8M | Buy |
329,690
+260,683
| +378% | +$19M | 0.13% | 141 |
|
|
2020
Q4 | $4.71M | Sell |
69,007
-25,303
| -27% | -$1.65M | 0.03% | 540 |
|
|
2020
Q3 | $5.51M | Buy |
94,310
+36,535
| +63% | +$2.27M | 0.04% | 313 |
|
|
2020
Q2 | $3.75M | Sell |
57,775
-69,380
| -55% | -$4.37M | 0.03% | 488 |
|
|
2020
Q1 | $7.54M | Buy |
127,155
+91,485
| +256% | +$6.11M | 0.07% | 258 |
|
|
2019
Q4 | $2.65M | Sell |
35,670
-239,520
| -87% | -$16.8M | 0.02% | 665 |
|
|
2019
Q3 | $17.4M | Buy |
275,190
+22,142
| +9% | +$1.31M | 0.14% | 117 |
|
|
2019
Q2 | $13.8M | Buy |
253,048
+80,794
| +47% | +$4.35M | 0.1% | 192 |
|
|
2019
Q1 | $9.29M | Buy |
172,254
+78,226
| +83% | +$4.83M | 0.09% | 240 |
|
|
2018
Q4 | $6.16M | Sell |
94,028
-57,685
| -38% | -$4.31M | 0.05% | 320 |
|
|
2018
Q3 | $11.9M | Buy |
151,713
+85,579
| +129% | +$6.12M | 0.09% | 235 |
|
|
2018
Q2 | $4.26M | Sell |
66,134
-14,361
| -18% | -$946K | 0.04% | 497 |
|
|
2018
Q1 | $5.01M | Sell |
80,495
-120,188
| -60% | -$8.62M | 0.04% | 422 |
|
|
2017
Q4 | $14.6M | Buy |
200,683
+167,729
| +509% | +$12.2M | 0.14% | 123 |
|
|
2017
Q3 | $2.68M | Sell |
32,954
-95,517
| -74% | -$7.56M | 0.02% | 622 |
|
|
2017
Q2 | $10.3M | Sell |
128,471
-25,768
| -17% | -$2.03M | 0.09% | 211 |
|
|
2017
Q1 | $12.1M | Sell |
154,239
-61,662
| -29% | -$4.92M | 0.11% | 178 |
|
|
2016
Q4 | $17M | Sell |
215,901
-51,440
| -19% | -$4.16M | 0.14% | 128 |
|
|
2016
Q3 | $23.8M | Buy |
267,341
+140,749
| +111% | +$13.3M | 0.25% | 72 |
|
|
2016
Q2 | $12.1M | Buy |
126,592
+103,816
| +456% | +$10.3M | 0.09% | 174 |
|
|
2016
Q1 | $2.36M | Sell |
22,776
-23,148
| -50% | -$2.25M | 0.02% | 762 |
|
|
2015
Q4 | $4.49M | Sell |
45,924
-654,886
| -93% | -$64.1M | 0.03% | 420 |
|
|
2015
Q3 | $7.6M | Buy |
700,810
+636,099
| +983% | +$66.9M | 0.05% | 279 |
|
|
2015
Q2 | $6.79M | Buy |
64,711
+3,590
| +6% | +$367K | 0.04% | 287 |
|
|
2015
Q1 | $6.31M | Sell |
61,121
-387,841
| -86% | -$39.2M | 0.04% | 332 |
|
|
2014
Q4 | $43.2M | Buy |
448,962
+297,867
| +197% | +$26.2M | 0.21% | 93 |
|
|
2014
Q3 | $12M | Sell |
151,095
-63,930
| -30% | -$5.04M | 0.07% | 280 |
|
|
2014
Q2 | $16.2M | Sell |
215,025
-499,732
| -70% | -$37.8M | 0.09% | 203 |
|
|
2014
Q1 | $53.5M | Buy |
714,757
+234,128
| +49% | +$16.5M | 0.23% | 98 |
|
|
2013
Q4 | $34.4M | Sell |
480,629
-265,806
| -36% | -$17.1M | 0.14% | 143 |
|
|
2013
Q3 | $42.4M | Buy |
746,435
+274,830
| +58% | +$16.4M | 0.17% | 115 |
|
|
2013
Q2 | $27M | Buy |
+471,605
| New | +$27.3M | 0.13% | 146 |
|
Other funds holding CVS
SG Americas Securities's CVS Position: Q2 2026 in Review
SG Americas Securities increased its CVS Health (CVS) stake by 58% in Q2 2026, buying an estimated $63.9M and bringing the position to 1,944,296 shares worth $201M. The position accounts for 0.11% of the portfolio, ranked #129.
SG Americas Securities first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- SG Americas Securities held 1,944,296 shares of CVS Health worth $201M as of Q2 2026.
- SG Americas Securities bought 716,227 CVS Health shares in Q2 2026, an estimated $63.9M.
- CVS Health made up 0.11% of SG Americas Securities's portfolio in Q2 2026, its #129 holding.
- SG Americas Securities first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.